AmkaiSolutions, an industry leader in providing innovative software solutions to ASCs, surgical hospitals and surgical practices, has worked with its surgery centers partners affected by the recent medication recall due to the nationwide meningitis outbreak to generate a special report through the AmkaiCharts electronic medical record to addresses associated federal and state audit requirements.
When AmkaiSolutions learned the recall had affected some its partners, the company created a report for the AmkaiCharts EMR that enabled users to type in the name of a drug, specify dosage, and specify date range when the medication was provided. In seconds, AmkaiCharts now provides a list of patients who received a specified drug in a date range, with demographic information for each patient.
"This is yet another example of how an EMR like AmkaiCharts is an invaluable tool for surgery centers," said Joe Macies, AmkaiSolutions CEO. "We generated and distributed the report within just a few hours of the first request from a client, allowing our partners to quickly begin working to meet the recall requirements. This experience just reinforces our promise to partners that AmkaiCharts has the capability and flexibility to report clinical data and trends to address nearly all needs and situations, even the unexpected."
The multistate fungal meningitis outbreak was attributable to contaminated steroid injections distributed nationwide to hospitals, surgery centers, and other providers by a Massachusetts compounding pharmacy. The pharmacy has since recalled all of its compounded and distributed products. Since several AmkaiSolutions' partner surgery centers received medications from the pharmacy, their states intend to conduct chart audits of the facilities to determine patient risk. The U.S. Food and Drug Administration has also required providers to notify patients who have been administered certain drugs produced by this pharmacy.
Learn more about AmkaiSolutions.
Related Articles on AmkaiSolutions:
AmkaiSolutions Expands Sales Team With Three New Regional VPs
ASC Leader to Know: Joe Macies of AmkaiSolutions
Timeline for the Transition to an ASC EMR: Before Integration (Part 1 of 3)
When AmkaiSolutions learned the recall had affected some its partners, the company created a report for the AmkaiCharts EMR that enabled users to type in the name of a drug, specify dosage, and specify date range when the medication was provided. In seconds, AmkaiCharts now provides a list of patients who received a specified drug in a date range, with demographic information for each patient.
"This is yet another example of how an EMR like AmkaiCharts is an invaluable tool for surgery centers," said Joe Macies, AmkaiSolutions CEO. "We generated and distributed the report within just a few hours of the first request from a client, allowing our partners to quickly begin working to meet the recall requirements. This experience just reinforces our promise to partners that AmkaiCharts has the capability and flexibility to report clinical data and trends to address nearly all needs and situations, even the unexpected."
The multistate fungal meningitis outbreak was attributable to contaminated steroid injections distributed nationwide to hospitals, surgery centers, and other providers by a Massachusetts compounding pharmacy. The pharmacy has since recalled all of its compounded and distributed products. Since several AmkaiSolutions' partner surgery centers received medications from the pharmacy, their states intend to conduct chart audits of the facilities to determine patient risk. The U.S. Food and Drug Administration has also required providers to notify patients who have been administered certain drugs produced by this pharmacy.
Learn more about AmkaiSolutions.
Related Articles on AmkaiSolutions:
AmkaiSolutions Expands Sales Team With Three New Regional VPs
ASC Leader to Know: Joe Macies of AmkaiSolutions
Timeline for the Transition to an ASC EMR: Before Integration (Part 1 of 3)